| payload |
{"created_at":"2026-04-21T12:20:48.730 {"created_at":"2026-04-21T12:20:48.730501+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/monthly-weight-loss-shot-why-pfizer-could-topple-lillys-and-novos-glp-1-duopoly","value":{"fp":"88dea56b0bea63fc","kind":"unusual_volume","published_at":"2026-04-21T11:50:00+00:00","source":"Nasdaq Markets","summary":"Key PointsNovo Nordisk and Eli Lilly are largely responsible for creating today's weight-loss drug market.","tickers":[],"title":"A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly","url":"https://www.nasdaq.com/articles/monthly-weight-loss-shot-why-pfizer-could-topple-lillys-and-novos-glp-1-duopoly"}}... |